Lægeformand kritiserer Novo Nordisks promovering af slankemedicin: 'Det stigmatiserer og skaber ulykkelighed' | BT Samfund - www.bt.dk
New guidance: Use drugs, surgery early for obesity in kids
Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM
Diabetes med Ozempic in short supply as Americans use it for weight loss
Semaglutid nun auch in Deutschland
Semaglutid: Warten auf Ozempic | APOTHEKE ADHOC
Novo dropper salg i Rusland af sit bedst sælgende lægemiddel
USA godkender ny fedmebehandling fra Novo Nordisk - TV 2
Semaglutide Shines as Weight Loss Therapy | MedPage Today
Semaglutid: Der Preis für das Abnehmen
Novo Nordisk, after obesity trial win for injectable semaglutide, plans test for oral version | Fierce Pharma
Frontiers | Safety of Semaglutide
Novo Nordisk reports positive results from SUSTAIN 9 trial
Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light | Fierce Pharma
HCP resources | OZEMPIC® ▽(semaglutide)
